Summary
A 24-year-old software engineer was granted a security clearance despite initial concerns under Guideline E (Personal Conduct) and Guideline H (Drug Involvement). The Statement of Reasons alleged that the applicant failed to disclose his illegal drug use on his October 2023 security clearance application and used marijuana for approximately two years, from 2021 to September 2023, during his college years.
Disqualifying conditions were raised under Adjudicative Guideline (AG) ¶ 16(a). However, the judge applied several mitigating conditions, specifically AG ¶ 26(a), AG ¶ 26(b), and AG ¶ 17(a).
The decision to grant the clearance was based on several factors. The applicant fully disclosed his marijuana use during a subsequent background interview, correcting his initial omission. He also demonstrated a clear commitment to abstain from future drug use and acknowledged the critical importance of honesty within the security clearance process. Furthermore, his drug use was limited to his college years, and he had not used marijuana since September 2023.
Why the Applicant Prevailed
- The applicant fully disclosed his marijuana use during a background interview after initially omitting it from his application.
- He demonstrated a commitment to abstain from drug use and acknowledged the importance of honesty in the clearance process.
- The applicant's drug use was confined to his college years, and he had not used marijuana since September 2023.
Conditions Referenced
- AG ¶ 16(a)raisedDeliberate Omission, Concealment, or Falsification of Relevant Facts
- AG ¶ 26(a)appliedBehavior Happened so Long Ago, Was Infrequent, or Unlikely to Recur
- AG ¶ 26(b)appliedAcknowledgment of Drug Involvement and Evidence of Actions Taken to Overcome the Problem
- AG ¶ 17(a)appliedPrompt, Good-faith Efforts to Correct the Omission
Key Rule Quoted
“The protection of the national security is the paramount consideration.”
Procedural Posture
- SOR issuedJul 15, 2024
- Answer filedJul 18, 2024
- Hearing held—Decision based on written record.
- Decision dateJul 1, 2025
Cite For
- Mitigating Factors for Drug Involvement Under Guideline H
- Importance of Full Disclosure During Background Investigations
- Consideration of the Whole-person Concept in Security Clearance Decisions